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It has been demonstrated that adult mice and hamsters, after an inapparent 
infection with polyoma virus, are resistant to the transplantation of an isologous 
polyoma tumor even though the challenge tumor no longer yields the original 
inducing  virus  (1,  5).  It was  shown  that  this  resistance  was  specific,  being 
effective against  only  those  tumors  originally  produced  by inoculating  new- 
borns with polyoma virus, and evidence was presented suggesting that serum 
antibodies,  either antiviral  or anticellular,  did not seem to be responsible for 
the resistance. To explain this phenomenon, it was postulated that the polyoma 
virus-induced  tumor contains  an antigen which is different from the  normal 
cellular antigens  of the  animal involved.  On  this basis, polyoma virus when 
inoculated into adult mice or hamsters causes a transformation of some normal 
cells to tumor cells containing a  new antigenic component which the immuno- 
logically competent adult  recognizes  as  a  foreign antigen  and  rejects.  In  so 
doing, tumor development due to the virus is suppressed and the adult becomes 
sensitized  to the tumor antigen.  A  later challenge with tumor cells causes an 
accelerated rejection, manifested by resistance to the tumor transplant. 
The studies reported here present direct and indirect evidence for the exist- 
ence of  the  previously postulated  "foreign"  antigen  in  the  polyoma tumors, 
and describe some of the characteristics of the development of the resistance. 
Materials and Methods 
Transplantable Tumor Lines.--Two  transplantable  fibrosarcomas originally induced in 
C$7B1/SJN mice by inoculation of newborns with  polyoma virus and a similarly induced 
hamster sarcoma have been previously described (2, 3). Most of the experiments now to be 
described used the 695 mouse tumor between its 20th and 30th transplant  passages. This 
tumor grows  more rapidly than the 1923 mouse tumor line. At the time of the resistance experi- 
ments, none of these tumors contained demonstrable virus or viral antigens, nor could virus 
production be induced in them by x-ray or ultraviolet irradiation. Trypsinized cell suspensions 
containing a determined number of viable tumor cells were inoculated subcutaneously (SC) 
in the interscapular area, and animals were observed for palpable tumors during 60 days. 
Female mice were used in all the experiments. 
18l 182  POLYOMA  VIRUS  ONCOGENESIS 
Virus Immunization.--Mouse  embryo  tissue  culture  grown polyoma  virus,  diluted  to 
contain 104 TCID of virus (0.1 ml of a  1/100  dilution), was inoculated intraperitoneally at 
least 4 weeks prior to challenge with tumor. 
X-ray lrradiation.--Whole  body irradiation with 400 to 425 r was carried out, as in previous 
experiments (1).  When cell suspensions were irradiated, they received 15,000 r. 
Serological Tests.--Hemagglutinin inhibition (HI) tests against virus were carried out,  as 
previously described (1). 
Ultraviolet Irradiation.--Ultraviolet-inactivated  vaccine was prepared by a  graded series 
of exposures of a mouse embryo tissue culture supernate containing l0  T TCID  of virus per ml 
in a Habel-Sockrider type of apparatus. Samples were tested for residual infectious virus by 
inoculation of mouse embryo tissue culture, and the indirect HI production test in mice (4). 
That sample, showing no viable virus at the shortest exposure, was used as vaccine. 
TABLE  I 
L~k  ~Tran~l~tal  Transfer ~  Resistame  to  Po~oma  Tumor 
Litters from 
Immune mothers ................... 
Normal mothers .................... 
No. of challenge  tumor cells 
lOS  10  4  I0~ 
3/6* 
4/8 
6/6 
7/S 
5/5 
8/8 
* No. developing tumors/No, inoculated. 
RESULTS 
Lack of Resistance to Tumor Challenge in Newborn Mice of Immune Mothers.- 
All virus-inoculated adult mice at the time of demonstrable resistance to the 
transplanted polyoma tumor have circulating antibodies against the polyoma 
virus,  and  will  be  referred  to  as  "virus-immune."  This  raises  the  question 
whether the antiviral antibodies are responsible for the resistance even though 
the  challenge tumor contains no virus  or viral antigens.  In  our preliminary 
report,  hyperimmune  antipolyoma  rabbit  serum  given  passively  to  normal 
adult mice  conferred no  resistance  to  tumor  challenge.  However,  since  that 
experiment involved heterologous species serum given over a  period of only 4 
days,  this  question was  now tested in  the homologous species.  Adult  female 
C57B1  mice were made immune  to polyoma virus,  and  1 month later were 
bred  with  normal  male  C57B1.  Litters  from  these  immune  mothers  with 
similar  litters  from  non-immune  mothers  were  challenged  with  695  tumor, 
when  1  or  2  days old.  Results  of one of two  experiments showing  the  same 
lack  of evidence of protection by antiviral antibody derived transplacentaUy 
from immune mothers is given in Table I. On the day of tumor challenge, the 
newborns of immune mothers had a  1/100 titer of polyoma HI antibodies in 
their sera. Had some other serum antibody, such as anticellular antibody, been 
present in the immune mothers and responsible for their resistance, it likewise 
had not been transferred to the newborns. ~RL  HAB~L  183 
Lack of Resistance  Following Immunization with Inactivated Virus and Mouse 
Embryo Cell Antigen.--Further evidence concerning the basis of resistance was 
sought  to  rule  out  any possible  anticellular  reactivity caused  by  the  small 
amount of mouse embryo cell antigens in the virus used to immunize the mice. 
Adult  C57B1  mice were inoculated with  either undiluted,  ultraviolet-inacti- 
vated polyoma tissue culture vaccine or the supernate from normal, uninfected 
mouse embryo cultures. Doses of 0.1, 0.2, and 0.5 mi at 2 week intervals were 
given intraperitoneally. All vaccinated mice and controls were challenged with 
the 695 tumor,  1 week after the last dose of vaccine. At that time, sera from 
both vaccinated groups were negative for HI antibodies against polyoma virus. 
Table II shows that the two vaccinated groups of mice were just as susceptible 
to tumor transplant as the controls, even though they had received 700 times 
as  much  embryo tissue  culture material  as  mice made resistant  by a  single 
dose of virus. 
TABLE II 
Lack of Resistanve to Tumor Challenge after Immunization with  Inactivated Virus 
Immunization 
Ultraviolet vaccine  .............. 
Normal METC* ................ 
Control ........................ 
I0  a 
0/5 
No. of challenge tumor cells 
1~  10  6 
~/~  s/s 
~/s  sis 
2IS  sis 
10e 
s/s 
5/5 
5/s 
* Supematant fluid from normal mouse embryo tissue cultures. 
Immunological  Incompetence  Gives  Enhanced  Susceptibility  to  Ttansplant 
Tumor.--If  the hypothesis that the polyoma tumor contains a foreign cellular 
antigen were true, then this should be a factor in the relative susceptibility of 
the normal adult mouse to tumor challenge unrelated to previous immuniza- 
tion with virus. This was indeed suggested by the fact that it usually required 
105 tumor cells to produce a  take in the normal adult. For direct evidence the 
immunological capability of mice was eliminated in two ways: by whole body 
x-irradiation of adults,  and by using newborn animals.  In Table III are the 
results of two experiments. Whole body x-irradiation of 400 r was given several 
hours before challenge. X-rayed normal adults were 10 times more susceptible 
to  tumor challenge than un-x-rayed adults,  and  normal newborns were  100 
times more susceptible than adults. Even mice already immunized with virus, 
then  x-rayed  at  time  of  challenge,  showed  less  resistance  than  un-x-rayed 
immunes,  suggesting  that  the virus-immune animal  already sensitized to the 
tumor antigen receives an antigenic booster effect from the challenge transplant. 
The basic resistance persists, but the booster effect is eliminated by irradiation. 184  POLYOMA  VIRUS  ONCOGENESIS 
Immunological  Tolerance  Produced  by  Tumor  Cells.--Further  evidence for 
the existence of a different antigen in tumor came from immunological tolerance 
experiments. Newborn C57B1 mice received 4  intraperitoneal inoculations of 
0.05 ml of a cell-free 10 per cent extract of the 695 tumor on days 1, 2, 3, and 
6  after  birth.  In  two  experiments,  the  mice  were  challenged  with  various 
numbers of 695  tumor cells on day 35 or 49, along with controls of the same 
age. There not only was no evidence of tolerance but some moderate degree of 
resistance in the inoculated, as compared with the control mice. On the other 
hand,  newborn  C~I-I mice  that  had  received  the  same  treatment  and  were 
challenged on the 36th day with the C57B1  tumor rejected the transplant in 
27 days, while normal C3H mice required only 13 days for complete rejection. 
More definite results with a  direct test were obtained when viable but non- 
TABLE III 
Immunological Basis  for Resistance to Polyoma Tumor Transplant 
Pretreatment  of mice 
Normal adult. 
Normal adult x-rayed*. 
Immune adult .... 
[mmune adult x-rayed* ..... 
Normal newborn. 
rumor extract immunized ..... 
No. of challenge tumor cells 
Experiment 1  Experiment 2 
i  lOJ  lO  s  106 
o/s 
o/s 
o/5 
o/5 
2/4 
o/5 
10  4  10  5 
~/s  s/s 
4/5  s/5 
o/s  alS 
--  4/5 
7/8  6/6 
0/5  3/5 
106  104 
5/s  0/s 
5/5  3/4 
4/S  0/5 
5/5  0/5 
7/7  -- 
sis  -- 
5/5 
5/5 
o/5 
3/5 
s/s 
5/5 
3/5 
5/5 
* 400 r  whole body irradiation. 
dividing tumor cells were used to inoculate the newborns. A trypsinized suspen- 
sion of 695 tumor cells was given 15,000 r x-irradiation and 106 cells inoculated 
subcutaneously or intraperitoneally at 1 and 3 days after birth. Challenge with 
tumor at 31 days gave results shown in Table IV in which the inoculated mice 
required only one-tenth the number of tumor cells as controls to establish  a 
positive transplant. 
One attempt to demonstrate tolerance in hamsters by inoculation of new- 
borns with x-rayed hamster tumor cells on days 1 and 3,  and challenge with 
the hamster transplantable tumor on day 59 showed partial resistance rather 
than  tolerance. The  tumors  of inoculated  animals  after  challenge were  less 
than half the size of those in the controls. 
Resistance to Transplant Produced by Immunization with Tumor Cells.--The 
last and most direct test for the presence of a non-C57B 1 antigen in the polyoma 
tumors, involved immunizing normal adult C57B1 mice with tumor cells and r~RL  a~EL  185 
later challenging with transplant. At the same time an attempt was made to see 
whether the same antigen existed in the two different mouse polyoma tumors 
and in the hamster tumor. The results of the first experiment are given in the 
last line of Table HI. Adult mice were immunized with a  20 per cent cell-free 
extract of 695 tumor by one inoculation of extract mixed with Freund's incom- 
plete adjuvant followed at 3  and 6  weeks with extract in  saline.  They were 
challenged at 7 weeks and showed only suggestive evidence of resistance. At the 
time of challenge sera were negative for polyoma HI antibodies. 
An attempt was made to immunize adult mice with viable tumor cells given 
intraperitoneally in 3  doses,  2 weeks apart.  Groups were inoculated with  10* 
ceils of 695 tumor,  10  ~ of 1923 tumor or 108 cells of the hamster tumor, and 
were challenged with 695 tumor cells 6 weeks from the start of immunization. 
TABLE IV 
Susceptibility of Mice to  Tumor  Challenge  as Adults  after Either  Polyoma  Virus or  Tumor 
Inoculation at Birth 
695 Challenge 
Pretreatment of mice 
I°____L_'  '___L__ 
Tolerant* ...............  12/515/51 
Virus infected~:  ........... /  0/5  ]  0/5  I 
Normal .................  ]0/5  13/4  I 
i0  s  1~ 
5/s  -- 
3/4  0/5 
5/5  o/s 
1923 Challenge 
106  106 
o/s  ]  1/4 
I  '/s  I  s/s 
* 10  e x-rayed 695 tumor cells subcutaneously on day 1 and intraperitoneally on day 3 
after birth.  Challenge at 31 days. 
~/104 to 10  s TCID of polyoma virus subcutaneously when 1 day old. Challenge at 37 
days. 
In spite of the immunizing doses of the mouse tumors being given intraperi- 
toneaily, very few receiving the 1923 cells survived for the challenge without 
developing intraperitoneal  tumors.  However, on the basis  of the  size of the 
tumor resulting from challenge, there was some resistance in the 695 immunized 
group.  Evidence for resistance in  the  1923  immunized group was  equivocal, 
owing to the small numbers available, yet both tumor incidence and the size 
of  the  single  tumor  measured  suggested increased  resistance.  There was  no 
evidence of resistance resulting from immunization with the hamster  tumor. 
(Table V). At the bottom of this table are the results of a different experiment 
in which C57B1 mice received a  single dose of 15  X  106 cells from a  parofid 
tumor produced by virus in a  C~I mouse. This tumor was also virus-free at 
the time of harvest. On challenge with 695 tumor, again the degree of resistance 
was  of questionable  statistical  significance but fewer tumors  were produced 
and they were much smaller in the immunized group. All animals at challenge 
were negative for HI antibodies. 186  POLYOMA  VIRUS ONCOGENESIS 
To be able to immunize mice with large amounts of the viable mouse tumor 
cells,  but  still  not  produce  tumors in  the  immunization  process,  tumor  cells 
were given 15,000  r x-irradiation. Mice received 1.7  X  106 x-rayed cells of 695 
tumor,  or 3.4  )<  105 x-rayed cells  of  1923  tumor intramuscularly,  and  were 
challenged  4  weeks  later.  A  second  attempted  method  of  immunizing  with 
viable  cells  involved  the  inoculation  of  106  cells  of  each  of  the  two  mouse 
tumors into  the  lower  thigh  of adult  C57B1  mice.  At  2  to  3  weeks  when  a 
definitely palpable  tumor  appeared,  the  involved leg  was  amputated.  These 
mice were also challenged at 4 weeks. The results of these two types of experi- 
ment  are  given in  Table VI.  It is  apparent  that  695  x-rayed cells produced 
definite  resistance  against  challenge  with  695,  and  also  to  1923.  The  1923 
TABLE  V 
Cross-Immunity to Polyoma Mouse Tumor  After Immunization with  Viable Tumor Cells 
Immunized with 
No. of 695 cells in challenge 
10  a  104  lO  b  106 
Experiment 1 
695 mouse  tumor  ..............  -- 
1923 mouse  tumor  ............. 
Hamster  tumor  ............... 
Controls  .......................  I  1/5 
Experiment 2  I 
CsH parotid tumor ............. 
Controls ....................... 
1/3 
0/3 
4/4 
2/5 
1/5  (1.0) 
2/5  (1.4) 
5/5  (9.6)* 
1/2  (6.s) 
5/5  (15.o) 
5/5  (15.2) 
3/s  (1.4) 
4/5  (7.4) 
5/5 
3/3 
5/5 
5/5 
3/4  (s.5) 
5/5  (15.0) 
* Average diameter of tumors in millimeters at 1 month after challenge. 
x-rayed  cells  on  the  other  hand  produced  no  evidence  of  resistance  against 
itself or 695. Mice whose 695 tumors had been removed by amputation showed 
no resistance to either tumor, whereas the 1923 amputated mice showed border- 
line evidence of resistance to both challenges. These differences might very well 
be related to the fact that 5 times more x-rayed 695  cells than 1923  cells were 
given as the immunizing dose, and that 695 tumors develop much more rapidly 
after transplantation than do the 1923 tumors. No HI antibodies were present 
at the time of challenge. 
Although  control  groups  immunized  with  normal  mouse  cells  were  not 
included  as  a  part  of  these  experiments,  it has been  shown  in  several other 
similar experiments that this gives no evidence of protection against challenge. 
This  would  be expected since  the  C57B1  mice are highly inbred  and  accept 
skin grafts from each other. 
One attempt was made to immunize adult hamsters with a  cell-free extract 
of hamster  tumor.  A  10  per  cent  homogenate  of hamster  tumor  was  frozen KARL  HABEL  187 
and thawed 3  times,  then mixed with Freund's incomplete adjuvant.  An intra- 
muscular  dose  of 0.5  ml  was followed  1 month  later  by 0.2  ml.  Seven weeks 
from  the  first  immunizing  dose,  the  hamsters  were  challenged  with  hamster 
tumor.  Table  VII  shows  that  none  of  the  immunized  hamsters  completely 
resisted the challenge, but the degree of tumor growth was definitely retarded 
as compared to control tumors. 
TABLE VI 
Cross-Immunization  between Two Mouse  Polyoma Tumors: Immunization  with  Viable Cells 
No. of challenge  tumor cells 
Immunization  695  1923 
10  s  [  10s 
695 x-rayed* ....... 
695 amputated* .... 
1923 x-rayed ....... 
1923 amputated... 
Control .......... 
10'  104 
0/5 2/5  (3.8) 
3/5  (6.8) 
4/4  (17.0) 
6/6  (15.8) 
2/3  (13.0) 
5/5  (16.2) 
4/5  (12.2) 
4/4  (20.0) 
10s  106 
--  4/4  (4.7) 
--  4/4  (22.5) 
--  6/6  (22.8) 
--  3/3  (15.3) 
4/4  (15.0)  4/4  (21.2) 
Figures  in parentheses  show average  diameter  in millimeters of tumors  1 month after 
challenge. 
* Cell suspension irradiated  with  15,000 r. 
:~ 105 tumor cells inoculated into thigh muscles and leg amputated when tumor palpable. 
TABLE VII 
Immunization  of Adult  Hamsters with Hamster Tumor Extract 
No. of challenge tumor cells 
10'  104  105  10s 
Immunized with tumor extract ...........  --  2/2  ~20)  2/2  (35)  2/2  (31) 
Controls ...............................  2/2  (8)  3/3  (33)  3/3  (63)  2/2  (62) 
Figures in parentheses  show average largest diameter of tumors  month after challenge. 
An  attempt  was  made  to  demonstrate  a  possible  relationship  between 
polyoma  hamster  tumor  and  mouse  tumor  antigens  by  challenging  virus- 
immune and normal  adults with  the heterologous tumor and determining  the 
time required for rejection of the transplant.  When immune and normal adult 
C57B1  mice  were  challenged  with  3  X  106  hamster  tumor  cells  or  normal 
hamster  embryo cells,  the heterologous transplants  were rejected in  the same 
period  of time  by both  groups.  The  same  was  true  when  normal  and  virus-- 
immune adult hamsters were challenged with 695 mouse tumor cells. However, 
when  virus-immune  and  normal  CsH  mice  were  challenged  with  4  X  106 188  POLYOMA  VIRUS  ONCOGENESIS 
cells  of  695  tumor,  the  polyoma-immune mice rejected  the  transplant  in  11 
days,  as  compared with  25  days  in  normal mice.  On  the  other  hand,  virus- 
immune  and  normal  Cj-I  mice  both  rejected  a  transplant  of  normal  adult 
C57B1 lung cells equally well in 11 days. 
Resistance  to  Tumor  Challenge  in  Virus-Immune  Mice  is  Cell-Mediated.- 
Since passive transfer of antiviral serum antibodies did  not induce resistance 
to tumor challenge in normal mice, the source of the resistance was investigated 
in  the  immunologicaUy competent  cells.  Adult  C57B1  mice which  had  been 
immunized with an inoculation of polyoma virus were challenged with  105 or 
106 cells of 695 tumor. Three months later those that had resisted the challenge 
along with normal mice of the same age were bled out. The spleens and axillary 
lymph nodes  were removed and passed through  a  tissue  sieve  and  the  cells 
inoculated  intraperitoneally  into  normal  adult  C57B1  mice.  Each  recipient 
TABLE VIII 
Transfer  of Resistance to  Tumor  Challenge by Spleen,  Thymus,  and  Bone Marrow Cells of 
Virus-Immune Mice 
No.  challenge tumor ceils 
Cells transferred from  Recipients 
10  4  10  5  10  6 
Virus-immune  ...........  X-irradiated*  0/3  2/2  -- 
None ..................  Unirradiated  3/5  5/5  5/5 
* 400 r whole body irradiation. 
received the ceils derived from one donor. Two days later the recipients were 
challenged  with  105  cells  of the  695  tumor.  All  mice developed  tumors,  but 
those that had received cells from immune mice had tumors progressing much 
more slowly than the tumors in recipients of normal cells. 
A  similar experiment used a  sieved cell preparation of spleen,  thymus, and 
bone marrow from C57B1  mice 5 weeks after being immunized with polyoma 
virus.  The  cells were given intraperitoneally  to  adult  C57B1  mice  that  had 
received 400 r  whole body x-irradiation. The controls were normal un-x-rayed 
adults.  Table VIII shows some protection against  the  tumor challenge  given 
5 days after the cell transfer. 
One further experiment involved the incubation of a mixture of lymph node 
cells from virus-immune or normal C57B1  mice with 695 ceils,  and subsequent 
inoculation of normal mice with these mixtures. Lymph node cell suspensions 
were prepared by trypsinization  of  the  nodes from  10  virus-immune and  10 
normal mice. 2  X  106 node cells from the virus immunes and 8  X  106 normal 
node cells were mixed with 6  X  1@ ceils from a  695  tumor. The cell mixtures 
suspended in 5 per cent calf serum-Eagle's medium were incubated with shaking H~L  189 
at 37°C for 2 hours, then the indicated numbers of cells were inoculated sub- 
cutaneously into 4 mice each. All 4 mice in each group developed tumors, but 
Fig. 1 shows that the tumor progression was slower in the virus-immune node 
recipients. 
Time  of Appearance  of Resistance  after Virus  Immunization.--Groups  of 
10 adult C57B1  mice each were given 1@ TCID  of polyoma virus intraperi- 
toneally on the indicated number of days before all were challenged with 695 
tumor. The results given in Table IX indicate that solid resistance developed 
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then inoculated  into  adult  mice.  Rate of  tumor growth. 
between the 6th and the 10th day after virus inoculation. Some mice receiving 
virus  on  the  same  day as  the  tumor  challenge also  were resistant  and  one 
wonders if the virus may have multiplied in and destroyed the tumor cells,  as 
we know from previous studies  (2)  it is  capable of doing  this  in vitro. Two 
months following the first challenge, all survivors without tumors were rechal- 
lenged with 695 tumor. Those that had resisted a  104 challenge were inoculated 
with 10  ~ cells, and those resistant to 105 were now given a  106 tumor cell chal- 
lenge.  In  general,  and  especially in  those given the  106 second challenge, it 
would appear that those groups most resistant to the first challenge were less 
resistant to the second. This is logical if we assume that at the time of original 
challenge these groups permitted little growth of the tumor before total rejec- 190  POLYOMA  VIRUS  ONCOGENESIS 
tion,  and  therefore,  less  opportunity for a  booster antigenic  effect.  In  these 
same groups, it is interesting that those mice that did resist the second challenge 
of 106 cells all developed small but definite tumors at the end of the 1st week 
which subsequently disappeared.  The fact that there was increased resistance 
to the second challenge is further evidence for the existence of a tumor antigen 
to which the mice have reacted. 
Resistance to Tumor Challenge in Mice Inoculated with Virus at Birth.--C57B 1 
newborn mice were inoculated intraperitoneally with 5 X  104 TCID of polyoma 
virus, and at 5 weeks of age were challenged with both 695 and 1923 tumors. 
TABLE IX 
Time  of Appearance of Resistance to  Tumor Transplant After  Immunizing  Inoculation of 
Polyoma Virus 
Virus inoculation  days 
before first challenge 
1 
3 
6 
10 
15 
20 
30 
Control--no virus 
10  4 
o/5 
0/5 
0/S 
0/5 
0/5 
0/S 
0/S 
0/S 
o/5 
No. of challenge  tumor cells 
First challenge 
105 
2/s 
5/5 
4/5 
2/5 
0/5 
0/5 
o/s 
1/5 
S/5 
Second challenge* 
10~  100 
0/5  1/3 
o/s 
4/5  0/1 
1/5  2/3 
3/5  3/5 
2/5  4/5 
o/s  3/5 
1/5  1/4 
s/5 
* Given 2 months after first challenge to those surviving without tumors. New Controls 
at this time had 5/5 at 105 and 2/5 at 104 challenge. 
The results are given under "Virus-infected" group, included in Table IV. With 
both  tumors  there was  some protection as  compared with  controls,  but  not 
the degree of resistance shown by virus-immunized adults. 
Virus Challenge of Adults Made Tolerant to Tumor.--According to our original 
hypothesis of the immunological basis for resistance in virus-immune mice,  an 
adult mouse made  tolerant  to  the foreign antigen  contained in  the polyoma 
tumor  should  develop  tumors  when  infected  with  virus.  Six  newborn  mice 
made tolerant by inoculation of x-irradiated 695 cells at birth were inoculated 
intravenously with  5  X  106 TCID  of polyoma virus when 32  days old.  Six 
normal mice of the same age were similarly inoculated. Other mice inoculated 
with irradiated  cells at the same time had been shown to be more susceptible 
to tumor challenge (Table IV). The mice inoculated intravenously with virus 
have been observed for 3 months to date with no evidence of tumors. KA_RL I:IABEL  191 
DISCUSSION 
Adult animals that have been given an immunizing inapparent infection by 
inoculation with viable polyoma virus are subsequently resistant to  a  trans- 
plant  of an isologous transplantable  polyoma tumor.  This phenomenon has 
been found by us in the case of three different polyoma tumors in one inbred 
strain  of mice  and  in  hamsters,  and it has  likewise been  reported  with  10 
tumors in 4 strains of mice by SjSgren et al.  (5) in Stockholm. In both labora- 
tories,  the  transplantable  polyoma  tumors  used  as  challenge  were  free  of 
demonstrable polyoma virus. Furthermore, we have shown that this resistance 
is specific  for tumors resulting from polyoma virus infection. In interpreting 
these findings, we have put forward the hypothesis that as the result of the 
inapparent virus infection of adult animals some normal ceils are transformed 
to tumor ceils  just as in newborns, and that these transformed cells  in both 
age groups contain a new "foreign" cell antigen. The new antigen is not recog- 
nized as foreign by the immunologically  immature newborn so a tumor develops, 
but  the  immunologically capable  adult  recognizes  the  foreign antigen  and 
rejects  it,  thus  preventing  tumor  development  and  becoming  sensitized  to 
tumor antigen. 
Evidence to support this hypothesis has been developed in the experiments 
reported here.  The existence of a  different or foreign cellular antigen in the 
polyoma tumors has been shown by the increased susceptibility to tumor chal- 
lenge in animals that are immunologically  incompetent; by the ability of tumor 
cell  antigens to  create  tolerance in  newborn mice  to  later  tumor challenge; 
and,  by the  production  of resistance  to  challenge  after immunization with 
tumor antigens. Furthermore, it has been shown that the resistance of virus- 
immune animals  is  not mediated by  serum  antibodies,  that  antiviral  anti- 
bodies are probably not involved and that this resistance like other transplanta- 
tion ~mmunity is cell-mediated by the immunologically competent spleen, bone 
marrow, and lymph node cells. 
The  experiments  reported  here  and  experiments  in  Dr.  George  Klein's 
laboratory in Stockholm (6) show that the "foreign" antigen present in polyoma 
tumors is similar from tumor to tumor in one inbred strain of mice, and also 
from  strain  to  strain.  However,  our  experiments  have  failed  to  show  any 
antigenic  relationship  between  polyoma  tumors  of  mice  and  those  of  the 
hamster.  This would suggest that by whatever intracellular mechanism the 
virus causes a  normal cell to transform to a  tumor cell, it permanently alters 
the genome to direct the production of a  new and immunologically different 
cell  antigen,  and  that  the  immunological structure  of the  tumor antigen is 
specific within a species as well as being specific for tumors produced by polyoma 
virus. 
Although the tumor antigen must represent an addition  of an antigen not 
present in  the normal cell,  it could still be  the result of a  loss  of a  genetic 
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reflected in the production of a  cell component of biochemical structure suffi- 
ciently different to represent a new antigen. However, once the virus has been 
responsible for the original transforming event, it may no longer be necessary 
or involved. From then on immunological factors may be limiting. Our present 
findings in part confirm a recently proposed hypothesis of Zilber (7), although 
he has suggested that the new tumor antigen caused by a virus might be the 
cause of increased proliferation. 
Even though  two simultaneously developing dynamic systems make  inter- 
pretations of time relationships difficult, nevertheless, when adult mice were 
challenged with tumor transplants at various intervals after virus inoculation, 
resistance  appeared  at  about  the  6th  day.  This means  that  sensitization  to 
tumor  antigen  develops  quite  rapidly  in  the  virus  inoculated  adult  mouse. 
According to our hypothesis,  this would be due to the fact that transformed 
cells  containing  tumor  antigen  were  present  within  a  few  days  after  virus 
inoculation.  On  the  other, hand,  when  newborn  mice  were  inoculated  with 
virus,  then challenged with tumor as adults,  they were found to be partially 
resistant.  This appears to be inconsistent with our hypothesis. If virus-inocu- 
lated newborn mice develop tumors because they are immunologically immature 
at  the time virus transforms normal cells,  then they ought to be tolerant to 
the tumor antigen rather than resistant. However, this brings up some inter- 
esting  questions  concerning  the  quantitative  aspects  of  transformation  by 
virus in relation to time, especially in the newborn where only a few days can 
make a big difference in the animal's immunological capabilities. If the newborn 
animal  has  only a  relatively few cells  transformed by virus,  the  number  of 
tumor cells,  and,  therefore, the antigenic mass  of the tumor antigen may be 
too small to establish tolerance. These cells then will persist into the period of 
immunological maturity with eventual sensitization and rejection. Furthermore 
in  all  of our experiments, it has been apparent  that  the resistance of virus- 
immune adults is not complete, but can be overcome by a  large enough chal- 
lenge.  Therefore,  the  balance  between  the  quantitative  efficiency of  trans- 
formation and  early  tumor  growth  on  the  one  hand,  and  the  developing 
immunological competence on the other, will determine the fate of the tumor. 
This may also be the basis for differences in the ease with which tumors can 
be produced by polyoma virus in newborn mice of different inbred strains.  It 
is  interesting  that  the  C57B1  mice  used  in  our  experiments are  not  highly 
susceptible to the tumor producing effects of the virus.  Further timed experi- 
ments with mouse strains of high and low susceptibilities to viral oncogenesis 
are required to answer this question. 
The demonstration of the immunological basis for the inability of polyoma 
virus to produce tumors in adult mice in spite of their high susceptibility to 
infection gives a logical explanation for the known facts concerning the ecology 
of polyoma virus in mouse populations under natural conditions. Although a ~B~L  193 
great deal of polyoma virus infection is spread in laboratory mouse colonies (8), 
as well as in wild mouse populations (9), a naturally occurring polyoma-induced 
tumor is  an  extreme rarity.  Unless  a  newborn mouse were exposed to very 
high concentrations of virus,  the quantitative and temporal factors discussed 
above might  well result in  the development of resistance.  Perhaps  the  only 
way  in  which  the  mouse,  naturally infected as  an  adult  or  infected with  a 
small  amount of virus as a  newborn mouse,  can develop a  polyoma-induced 
tumor is by the chance occurrence of some event which temporarily reduces its 
immunological competence at  the proper time  after virus  transformation  of 
normal cells to tumor cells. 
SUM-~ARY 
Adult mice and hamsters can be made resistant to an isologous transplantable 
polyoma tumor by an inapparent infection with polyoma virus. This resistance 
is  cell-mediated and  seems not  to be related  to anti-viral  serum antibodies. 
The basis  of the resistance  appears  to be  a  transplantation  type of cellular 
immunity directed against  a  "foreign" antigen  contained in  the  tumor  cell. 
Evidence has been presented to demonstrate this tumor antigen. It is possible 
that this phenomenon may explain the lack of oncogenesis by polyoma virus 
infection of adult mice, and the rarity of naturally occurring polyoma tumors. 
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